RSV is a common virus that affects the lungs and breathing passages, and here are some steps you can take to protect yourself ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

Stay home if they are sick until they no longer have a fever for 24 hours without using fever-reducing medicine. Return to ...

COVID-19 was associated with more severe disease outcomes than influenza or RSV during the 2022 to 2023 season.

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...